Results: 5

3.
Figure 3

Figure 3. From: A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells.

Profiling of ML281 (1 μM) against a panel of 83 kinases.

Michel Weïwer, et al. ACS Med Chem Lett. 2012 December 13;3(12):1034-1038.
5.
Figure 4

Figure 4. From: A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells.

Effect of ML281 on KRAS-dependent (red) and KRAS-independent (blue) cell viability.

Michel Weïwer, et al. ACS Med Chem Lett. 2012 December 13;3(12):1034-1038.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk